US Patent 7250180 Anti-prostate cancer composition and therapeutic uses therefor
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+342 characters)
Article
Patent abstract
Disclosed are methods and compositions useful in treating prostate cancer. The invention is based on BIRM, an extract of the plant Solanaceae-Dulcamara and its previously unrecognized anti-prostate cancer activity. Also disclosed are methods for preparing compositions for administration to humans for treating prostate cancer.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07250180 Anti-prostate cancer composition and therapeutic uses therefor US Patent 7250180 Anti-prostate cancer composition and therapeutic uses therefor
Infobox
Patent Number
0725018000
Patent Number
725018000
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072501800
Date of Patent
July 31, 2007
0Patent Application Number
107540770
Date Filed
January 7, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072501800
Date of Patent
July 31, 2007
0Patent Application Number
107540770
Date Filed
January 7, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07250180 Anti-prostate cancer composition and therapeutic uses therefor
Infobox
Is a
Patent jurisdiction
Patent number
07250180
Date of patent
July 31, 2007
Patent application number
10754077
Date Filed
January 7, 2004
Patent primary examiner
Find more entities like US Patent 7250180 Anti-prostate cancer composition and therapeutic uses therefor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
